Most of what's written about GLP-1 medications and periods focuses on semaglutide (Ozempic, Wegovy). Tirzepatide — the active ingredient in Mounjaro and Zepbound — works a bit differently, and the picture for your cycle is worth its own look.
Tirzepatide is a "dual agonist" — it activates both the GLP-1 receptor and a second one called GIP, instead of just GLP-1 alone. In practice, this tends to produce somewhat greater average weight loss than semaglutide in head-to-head data, which matters here because most cycle changes trace back to the pace of weight change, not the drug acting on the uterus directly.
Worth knowing: official prescribing information for Mounjaro doesn't list menstrual changes as a confirmed side effect — the mechanism is indirect, through weight and metabolic shifts, not a direct drug effect on the reproductive system.
This is where the effect tends to be most noticeable. Many people with PCOS report their cycle becoming regular for the first time in years as insulin sensitivity improves — a real, mechanistically-explained effect, not a coincidence. It's also why unplanned pregnancy has become a genuinely discussed topic among tirzepatide users who assumed their irregular cycles meant low fertility risk.
Track your doses next to your cycle so you can see your own pattern instead of guessing. If you're on any oral hormonal medication — contraceptive or HRT — talk to your prescriber about backup protection during the windows above. And if periods stop for three months or more outside what's expected for you, or bleeding becomes unusually heavy, that's worth a clinical conversation regardless of the likely cause.
Sicavie tracks your cycle and your GLP-1 doses on the same timeline — free for 7 days.
Try it freeThis page is general information, not medical advice, and isn't a substitute for care from your doctor or pharmacist. Talk to your prescriber about contraception or HRT timing specific to your situation.